NASDAQ:XCUR - Nasdaq - US30205M3097 - Common Stock - Currency: USD
7.61
-0.09 (-1.17%)
The current stock price of XCUR is 7.61 USD. In the past month the price decreased by -33.94%. In the past year, price increased by 104.57%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 20.06 | 358.75B | ||
AMGN | AMGEN INC | 15.46 | 164.53B | ||
GILD | GILEAD SCIENCES INC | 23.96 | 137.63B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1652.07 | 123.08B | ||
REGN | REGENERON PHARMACEUTICALS | 15.49 | 77.28B | ||
ARGX | ARGENX SE - ADR | N/A | 37.86B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.45B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.64B | ||
BNTX | BIONTECH SE-ADR | N/A | 27.33B | ||
NTRA | NATERA INC | N/A | 21.20B | ||
BIIB | BIOGEN INC | 8.53 | 20.47B | ||
INCY | INCYTE CORP | 56.29 | 14.38B |
Exicure Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Chicago, Illinois and currently employs 6 full-time employees. The company went IPO on 2018-05-09. Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The firm is into exploring strategic alternatives to maximize stockholder value. The company is engaging in a broader exploration of strategic alternatives. This effort involves exploring growth through transactions with potential partners that see opportunity in joining an existing, publicly traded organization. The firm is exploring transactions in industries unrelated to its historical operations. The company does not generate any revenues. The company wholly owned subsidiary is Exicure Operating Company that holds all material assets and conducts all business activities and operations of the Company.
EXICURE INC
2430 N. Halsted St.
Chicago ILLINOIS 60614 US
CEO: David A. Giljohann
Employees: 5
Company Website: https://www.exicuretx.com/
Investor Relations: http://investors.exicuretx.com/overview/default.aspx
Phone: 18476731700
The current stock price of XCUR is 7.61 USD. The price decreased by -1.17% in the last trading session.
The exchange symbol of EXICURE INC is XCUR and it is listed on the Nasdaq exchange.
XCUR stock is listed on the Nasdaq exchange.
EXICURE INC (XCUR) has a market capitalization of 19.86M USD. This makes XCUR a Nano Cap stock.
EXICURE INC (XCUR) currently has 5 employees.
EXICURE INC (XCUR) has a support level at 7.6 and a resistance level at 8.56. Check the full technical report for a detailed analysis of XCUR support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
XCUR does not pay a dividend.
EXICURE INC (XCUR) will report earnings on 2025-06-04, after the market close.
EXICURE INC (XCUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.26).
The outstanding short interest for EXICURE INC (XCUR) is 3.72% of its float. Check the ownership tab for more information on the XCUR short interest.
ChartMill assigns a technical rating of 2 / 10 to XCUR. When comparing the yearly performance of all stocks, XCUR is one of the better performing stocks in the market, outperforming 85.43% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to XCUR. While XCUR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months XCUR reported a non-GAAP Earnings per Share(EPS) of -2.26. The EPS decreased by -231.93% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -37.69% | ||
ROE | -259.35% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to XCUR. The Buy consensus is the average rating of analysts ratings from 6 analysts.